Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
In the absence of identified therapeutic targets, chemotherapy is the main systemic treatment option for triple-negative breast cancer (TNBC). The achievement of a pathological complete response (pCR) after neoadjuvant chemotherapy leads to good outcome, whereas patients not achieving a pCR are at h...
Main Authors: | Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte, Massimo Calabrese, Alba Fiorentino, Caterina Marchiò, Corrado Tinterri, Veronica Andrea Fittipaldo, Giovanni Pappagallo, Stefania Gori |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1137 |
Similar Items
-
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
by: Federica Miglietta, et al.
Published: (2022-12-01) -
GRADE: Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
by: Schünemann, H, et al.
Published: (2008) -
Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations.
by: Brożek, J, et al.
Published: (2011) -
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
by: Nicola Silvestris, et al.
Published: (2020-06-01) -
GRADE: assessing the quality of evidence for diagnostic recommendations.
by: Schünemann, H, et al.
Published: (2008)